Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446]

Ítems similars

• Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial
  per: Ziegler, Ralph, et al.
  Publicat: (2013)
• Safe and Efficacious Use of Automated Bolus Advisors in Individuals Treated With Multiple Daily Insulin Injection (MDI) Therapy: Lessons Learned From the Automated Bolus Advisor Control and Usability Study (ABACUS)
  per: Parkin, Christopher G., et al.
  Publicat: (2015)
• Use of Automated Bolus Advisors May Improve Adherence to Multiple Daily Insulin Injection Therapy
  per: Barnard, Katharine, et al.
  Publicat: (2012)
• Efficacy of bolus insulin calculation by a mobile-based bolus advisor: An open label clinical trial
  per: Siavash, Mansour, et al.
  Publicat: (2015)
• An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning
  per: Taiyu Zhu, et al.
  Publicat: (2020-09-01)